Dr. Suresh S. Ramalingam

The phase 3 LAURA trial showed that treatment with Tagrisso (osimertinib) continued to have an encouraging overall survival trend in patients with unresectable, stage 3 EGFR-mutated non-small cell lung cancer (NSCLC) following chemoradiotherapy, according to a news release which detailed […]

Patients with stage 3 lung cancer often receive chemotherapy and radiation, which can cause lung inflammation known as radiation pneumonitis, according to Dr. Suresh S. Ramalingam. Dr. Suresh Ramalingam is a board-certified medical oncologist specializing in small cell and non-small